申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:US20170355707A1
公开(公告)日:2017-12-14
Disclosed are compounds of Formula (I) or a salt thereof; wherein: X is N or CH; Q
1
is: (i) Cl, Br, I, —CN, —CH
3
, or —CF
3
; (ii) a 5-membered heteroaryl selected from pyrrolyl, pyrazolyl, imidazolyl, oxazolyl, thiazolyl, triazolyl, oxadiazolyl, and thiadiazolyl; (iii) a 6?membered heteroaryl selected from pyridinyl, pyridazinyl, and pyrimidinyl; or (iv) a bicyclic heteroaryl selected from indolyl, pyrrolopyridinyl, pyrazolopyridinyl and benzo[d]oxazolyl; wherein each of said 5-membered, 6-membered, and bicyclic heteroaryl is substituted with zero to 1 R
a
and zero to 1 R
b
; and R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, R
a
, and R
b
are defined herein. Also disclosed are methods of using such compounds as modulators of PI3K, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing inflammatory and autoimmune diseases.